Baylor College of Medicine

Washington Research Foundation

Other

University of Southern California

Howard Hughes Medical Institute

Savio L Woo

Earl W Davie

Louis C Smith

Kotoku Kurachi

Richard J Cristiano

Jim Sparrow

Stephen Gottchalk

Chandra Thirumalachary

Shu-Hsia Chen

Anthony G Dilella

Peter W Nordloh

Arne Stenlund

Harold C Slavkin

Malcolm L Snead

Margarita Zeichner-David

Nucleic acid transporter systems for delivery of nucleic acid to a cell. The nucleic acid transporter includes a binding complex. The binding complex contains a binding molecule which non-covalently binds to the nucleic acid and covalently links to a surface ligand, nuclear ligand and/or a lysis agent. These may be linked to the binding molecule by spacers.

Nucleic acid transporter systems and methods of use

Gene therapy for solid tumors using adenoviral vectors comprising

DNA sequences to mammalian .alpha..sub.1 -antitrypsin are provided which can be used for expression of mammalian .alpha..sub.1 -antitrypsin. This work was supported in part by grants HL16919 and HL27509 from the National Institutes of Health.

DNA sequences expressing mammalian .alpha..sub.1 -antitrypsin

Nucleic acid transporter system and methods of use

DNA sequences expressing mammalian .alpha..sub.1 antitrypsin

An episomal vector sytem and methods for use in gene therapy in humans and animals. The vector contains a papilloma virus origin of replication, a vector maintenance sequence, a first promoter transcriptionally linked to a therapeutic nucleic acid sequence, a second promoter transcriptionally linked to a papilloma virus E1 gene sequence, and a third promoter transcriptionally linked to a papilloma virus E2 gene sequence or an E1/E2 fusion gene. The vector is capable of episomal replication in human or animal cells.

Episomal vector systems and related methods

The present invention provides a novel method of treating localized solid tumors and papilloma in an individual. The method comprises introducing a recombinant adenoviral vector containing the herpes simplex virus-thymidine kinase gene. Subsequently, a prodrug, such as the drug ganciclovir, is administered to the individual. The methods of the present invention may be used to treat several different types of cancers and papillomas, including colon carcinoma, prostate cancer, breast cancer, lung cancer, melanoma, hepatoma, brain and head and neck cancer.

Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or

DNA sequences to mammalian .alpha..sub.1 -antitrypsin are provided which can be used for expression of mammalian .alpha..sub.1 -antitrypsin.

DNA sequences expressing mammalian alpha-1-antitrypsin

Disclosed is a method for detection of the mutation in phenylalanine hydroxylase genes. This method can be used for the detection of PKU affected, PKU heterozygotes and normals. Also disclosed are oligonucleotides synthesized to detect the first mutations identified in the human phenylalanine hydroxylase gene. The synthesized probes have base pair mismatches with genomic DNA to facilitate the diagnosis of normal and mutant phenylalanine hydroxylase genes. A simple method for detection of the genetic trait, PKU, without obtaining a previous family history of PKU is provided.

Methods for the identification of mutations in the human phenylalanine

Methods are provided for the formation of dental enamel crystals in biosynthetic matrix form by the nucleation of calcium solutions with enamel proteins and for the use of such enamel crystals as restorative material.

Dental enamel production

Growing community of inventors

Houston, TX, United States of America

Savio L Woo